Allscripts Announces Fourth Quarter and Fiscal Year 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Allscripts (MDRX) Tops Q4 EPS by 54c
February 24, 2022 4:04 PM ESTAllscripts (NASDAQ: MDRX) reported Q4 EPS of $0.79, $0.54 better than the analyst estimate of $0.25. Revenue for the quarter came in at $392 million versus the consensus estimate of $386.75 million.
GUIDANCE:
For the full year 2022, Allscripts currently expects to achieve:
Consolidated free cash flow from... More
